Integra Lifesciences (NSDQ:IART) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Princeton, N.J.-based surgical and medical instrument company reported profits of $45.4 billion, or 53¢ per share, on sales of $405.5 million for the three months ended Dec. 31, 2021, for a sales growth of 4.34% compared with Q4 2020. […]
Penumbra posts mixed-bag Q4 results, grows sales 22%
Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Alameda, California-based company reported losses of -$24.6 million, or -66¢ per share, on sales of $204 million for the three months ended Dec. 31, 2021, for a sales growth of 22.24% compared with Q4 2020. Get […]
Front Line Medical expands availability of COBRA-OS arterial occlusion system
Front Line Medical recently announced that it expanded the availability of its COBRA-OS aortic occlusion device to meet growing demands. The Ontario, Canada-based company is increasing production of the COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) occluder following patient success rates and expanded interest from hospitals to treat trauma. Get the full story on […]
FDA clears Dyad Medical automated cardiac image analysis platform
Dyad Medical this week announced that it received FDA 510(k) clearance for its Libby IAAA cardiac image analysis platform. Boston-based Dyad Medical designed the Libby IAAA for image analysis used for viewing and quantifying intravascular optical coherence tomography (IVOCT) images. It allows healthcare professionals to automate intravascular investigation and see inside of blood vessels to […]
MicroVention announces first U.S. clinical case using aneurysm flow diverter Fred X
MicroVention today announced that the first U.S. clinical case of its flow diverter Fred X device was performed at Thomas Jefferson University Hospital in Philadelphia. Aliso Viejo, California-based MicroVention received premarket approval for the Fred X device in September. It uses a self-expanding braided nitinol mesh to redirect blood flow and promote aneurysm occlusion. The […]
Medtronic wins FDA expanded approval to use cardiac cryoablation catheters in kids
Medtronic today announced that it received FDA expanded approval for its Freezor and Freezor Xtra cardiac cryoablation catheters for pediatric atrioventricular nodal reentrant tachycardia (AVRNT). AVNRT is the most common form of supraventricular tachycardia and involves a life-threatening abnormal heart rhythm. More than a third of AVRNY cases are in pediatrics or children under the age […]
Shockwave Medical up on 270% sales growth in Q4
Shockwave Medical (NSDQ:SWAV) posted fourth-quarter results that beat the overall consensus on Wall Street. The Santa Clara, California-based company has proprietary cardiovascular disease treatment tech involving local delivery of sonic pressure. Yesterday evening it reported profits of $12.9 million, or 34¢ per share, on sales of $84.2 million for the three months ended Dec. 31, […]
Baxter profits up 42% in Q4
Baxter (NYSE:BAX) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Deerfield, Illinois-based company reported profits of $242 million, or 47¢ per share, on sales of $3.5 billion for the three months ended Dec. 31, 2021, for a bottom-line gain of 41.5% on sales growth of 10.5% compared with Q4 2020. Adjusted […]
AtriCure publishes first environmental, social, governance report
AtriCure (NASDAQ:ATRC) this month released its first environmental, social and governance (ESG) report that highlights the company’s corporate responsibility and sustainability initiatives. Companies produce corporate responsibility for corporate stakeholders who are interested in ESG-related information. AtriCure’s ESG report includes data metrics such as the gender diversity of its management and workforce and the racial diversity […]
AtHeart Medical wins FDA approval for second phase of ASD occluder IDE study
AtHeart Medical recently announced that it received FDA approval to commence the second phase of its Ascent ASD investigational device exemption pivotal trial. Switzerland-based AtHeart Medical is evaluating the safety and efficacy of the reSept atrial septal defects (ASD) occluder in a prospective, single-arm study. The reSept device is metal-free with a bioresorbable frame designed to […]
TytoCare wins CE mark for lung sound analyzer
TytoCare this week received CE mark approval for its Tyto Lung Sounds Analyzer for remote medical exams. The New York-based company designed the AI-powered Tyto Lung as a web-based software module that adds more capabilities to the existing TytoCare portfolio. It processes recordings from the company’s off-the-shelf compatible electronic TytoCare stethoscope and aids in the […]